Gene therapy is the one remaining therapeutic option for treating severe combined immunodeficiency by correcting it at its most fundamental genetic level.
Advancements in stem cell therapy may soon eliminate surgeries and cure disease, but first, the debate between two different schools of thought concerning how best to proceed needs to be resolved.
New extended half-life products represent a powerful new tool for improving the care and quality of life for persons with hemophilia.
As the number of cancer cases continues to rise, scientists are bringing to light exciting discoveries that are being used to create targeted therapies to treat and, it is hoped, to eventually cure cancer.
Despite its near eradication in the U.S., whooping cough is making a comeback due to disproven claims and reduced vaccine effectiveness.
Vaccination against these four specific diseases is recommended prior to travel to endemic areas.
Childhood vaccines are widely recognized as safe, but a growing minority of parents are choosing not have their children immunized.
Recent U.S. Food and Drug Administration advisory committee strain recommendations could make this season’s influenza (flu) vaccine more effective than ever. But, will an epidemic of public apathy undermine immunization efforts?
The efficacy of influenza (flu) vaccines has been greatly improved over the past several decades, but the flu virus still severely sickens hundreds of thousands of individuals each year. Is it possible that scientists have discovered a way to change that?
Hard-to-treat bacterial skin infections are becoming more common. A better understanding of them is the first step toward improving treatment.
Polio still plagues a few parts of the world, and some of its past victims are vulnerable to a recurrence but in a less serious form.
The plasma donor is the first vital part of the process to produce safe and effective plasma protein therapeutics, and the industry prioritizes the safety and health of its plasma donors.
